Item 7.01 Regulation FD Disclosure.

On January 18, 2022, Salona Global Medical Device Corporation (the "Company") held a telephonic conference call to discuss, among other matters, the results for the quarter ended November 30, 2021 and general corporate matters. The transcript of the conference call is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01, including Exhibit 99.1 , is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of Section 18, (and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933 or the Exchange Act), except as shall be expressly set forth by specific reference in any such filing. This Current Report will not be deemed an admission as to the materiality of any information contained in this Item 7.01, including Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits



(d) Exhibits

         Exhibit   Description

           99.1      Transcript of presentation by the Company on January 18,
                   2022.
         104       Cover Page Interactive Data File (embedded within the Inline
                   XBRL document)

© Edgar Online, source Glimpses